Actavis launches Montelukast as patents expire in Europe – PharmaLive (press release) (subscription)

Actavis launches Montelukast as patents expire in Europe
PharmaLive (press release) (subscription)
In Austria, Actavis started pricing and reimbursement on Day 1. The generic equivalent of Merck's SingulairĀ®, Montelukast tablets are indicated for the treatment of asthma. Montelukast Actavis is available as regular tablets for ages 15 years and

and more »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *